CareDx News Releases https://investors.caredxinc.com/ CareDx News Releases en CareDx to Participate in Upcoming Conferences https://investors.caredxinc.com/news-releases/news-release-details/caredx-participate-upcoming-conferences-0 BRISBANE, Calif. , June 10, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Mon, 10 Jun 2019 08:00:00 -0400 CareDx News Releases 11356 CareDx Announces KidneyCare and Showcases Leadership in Transplantation at ATC https://investors.caredxinc.com/news-releases/news-release-details/caredx-announces-kidneycare-and-showcases-leadership CareDx leadership in transplant innovation highlighted through 12 podium and poster presentations BRISBANE, Calif. , May 29, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically Wed, 29 May 2019 08:00:00 -0400 CareDx News Releases 11321 CareDx to Participate in Upcoming Conferences https://investors.caredxinc.com/news-releases/news-release-details/caredx-participate-upcoming-conferences BRISBANE, Calif. , May 22, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today announced that Peter Wed, 22 May 2019 08:36:00 -0400 CareDx News Releases 11306 CareDx applauds HHS Report on Cost Savings of Lifetime Immunosuppressive Drug Coverage for Transplant Patients https://investors.caredxinc.com/news-releases/news-release-details/caredx-applauds-hhs-report-cost-savings-lifetime Extending Medicare coverage of medication saves $73M BRISBANE, Calif. , May 14, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions Tue, 14 May 2019 08:33:00 -0400 CareDx News Releases 11291 CareDx Reports First Quarter 2019 Results https://investors.caredxinc.com/news-releases/news-release-details/caredx-reports-first-quarter-2019-results AlloSure momentum drives 85% first quarter revenue growth BRISBANE, Calif. , May 08, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (NASDAQ: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for Wed, 08 May 2019 16:01:00 -0400 CareDx News Releases 11256 CareDx’s AlloSeq cfDNA and QTYPE Solutions Featured at EFI 2019 https://investors.caredxinc.com/news-releases/news-release-details/caredxs-alloseq-cfdna-and-qtype-solutions-featured-efi-2019 CareDx leadership in transplant innovation highlighted through multiple podium and poster presentations BRISBANE, Calif. , May 07, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on the discovery, development, and commercialization of Tue, 07 May 2019 09:00:00 -0400 CareDx News Releases 11251 AlloMap In-Network with Anthem Blue Cross https://investors.caredxinc.com/news-releases/news-release-details/allomap-network-anthem-blue-cross AlloMap now in-network for over 80% of covered lives with all US payors BRISBANE, Calif. , May 03, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic Fri, 03 May 2019 08:00:00 -0400 CareDx News Releases 11241 CareDx Adds iBox Technology, Next Step Towards Artificial Intelligence in Transplant Care https://investors.caredxinc.com/news-releases/news-release-details/caredx-adds-ibox-technology-next-step-towards-artificial CareDx collaboration with Cibiltech provides prognostic information on allograft survival BRISBANE, Calif. , May 02, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, Thu, 02 May 2019 08:00:00 -0400 CareDx News Releases 11236 CareDx Agrees to Acquire OTTR Complete Transplant Management https://investors.caredxinc.com/news-releases/news-release-details/caredx-agrees-acquire-ottr-complete-transplant-management OTTR acquisition will enable EMR integrations at transplant centers and longitudinal patient data management BRISBANE, Calif. , April 25, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically Thu, 25 Apr 2019 16:01:00 -0400 CareDx News Releases 11216 CareDx to Announce First Quarter 2019 Financial Results on May 8th, 2019 https://investors.caredxinc.com/news-releases/news-release-details/caredx-announce-first-quarter-2019-financial-results-may-8th BRISBANE, Calif. , April 23, 2019 (GLOBE NEWSWIRE) -- CareDx , Inc. (Nasdaq: CDNA), a leading molecular diagnostics company focused on creating diagnostic solutions for organ transplant patients, today announced that it will release financial results for the first quarter 2019 after the market Tue, 23 Apr 2019 08:00:00 -0400 CareDx News Releases 11211